COVID-19 Perspectives Series Part III – Q&A with David Priebe, Chairman, Guy Carpenter: David Priebe offers COVID-19 insights on investment portfolio impact on (re)insurance pricing, pricing momentum amid economic challenges, alternative capital and communicable disease exposures and exclusions in an interview with The Insurer held on April 13. This is Part Three of a three part series.
Navigating the Pandemic’s Next Waves: Risk-based management came into its own in the 2008-2009 financial crisis, amidst huge market turbulence and massive government intervention, according to Anthony Bice and Michael Moloney, Partners in Oliver Wyman’s Financial Services group and Head of EMEA Insurance and Americas Insurance, respectively. Add fear for human life and deliberate restriction of normal societal functioning and you’ve got today’s novel coronavirus (COVID-19) pandemic — negatively impairing almost all financial and operational aspects of businesses at once.
Responding to COVID-19 in Brazil: Around the world lockdown measures have been put in place to flatten the COVID-19 contagion curve and alleviate impact on health systems. The side effect, however, has been a profound and unprecedented negative impact in the real economy. In a research report, Guy Carpenter-affiliate Oliver Wyman offers its perspective on the short- and potential medium-term effects of COVID-19 on Brazil.
Regional Inequalities – Protecting our Planet and the Public Purse: Climate change is a top priority for companies and governments around the world, but it will not impact all geographies in the same way, or to the same degree. Guy Carpenter’s new report, Protecting our Planet and the Public Purse, looks into the potential for accentuated global inequalities under climate change and how the protection gap falls across higher and lower income groups.
Estimating the Impact of COVID-19 on the U.S. Medical (Re)Insurance Market: As the COVID-19 situation is changing on a daily basis, the impact to the insurance and reinsurance markets is not yet fully known. However, given the significance of the developments, Guy Carpenter provides our view of how COVID-19 may impact the medical (re)insurance market.
And you may have missed..
Benchmarking COVID-19 – An Actuarial Perspective: Leveraging publicly available information and the insights of a variety of in-house specialists, including those that helped create the original U.S. Centers for Disease Control and Prevention (CDC) pandemic response protocols, Oliver Wyman has prepared some actuarial considerations to assist insurers assessing COVID-19’s potential impact to their business.
